文献速递甲状腺疾病

儿童及青少年分化型甲状腺癌随访中的动态风险分层

Dynamic Risk Stratification in the Follow-Up of Children and Adolescents with Differentiated Thyroid Cancer.
PubMed 文献 · Thyroid · 2018-01-01

初始治疗后按DRS分类,多数患者6年后仍维持原分类;术后刺激状态下甲状腺球蛋白(sPOTg)37.8 ng/mL预测极好反应的灵敏度81%、特异度100%。DRS和sPOTg是疾病结局的强预测因素。

要点

  • 儿童及青少年DTC初始治疗后DRS分类可预测疾病结局。
  • sPOTg 37.8 ng/mL预测极好反应灵敏度81%、特异度100%。
  • 多数患者随访6年后DRS分类保持不变。

核心结论

  • 初始治疗后DRS和sPOTg是儿童及青少年DTC疾病结局的强预测因素,可能有助于制定随访策略。

主要发现

  • 诊断时颈部转移41例(63.1%),远处转移18例(27.7%)。
  • 全部患者行甲状腺全切,63例(95.5%)接受放射性碘治疗。
  • 初始治疗后DRS分类(n=63):极好反应21例(33%)、不确定13例(21%)、生化不全6例(9%)、结构不全23例(37%)。
  • 中位随访6年(P25-75 2.7-10.0)后多数患者DRS分类保持不变。
  • 单因素分析中与持续疾病相关的预后因素包括TNM、ATA风险、DRS和sPOTg。

关键数值与推荐

  • sPOTg 37.8 ng/mL预测极好反应的灵敏度81%、特异度100%。
  • ATA风险依据2015年美国甲状腺协会儿童DTC指南风险分层系统分类。
  • DRS分类为极好、不确定、生化不全或结构不全反应。

临床怎么用

  • 儿童及青少年DTC初始治疗后可采用DRS进行动态风险分层以指导随访。
  • sPOTg 37.8 ng/mL可作为预测极好反应的参考阈值。

局限性

  • 原文未报告多因素分析结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Risk stratification for persistent disease is an important step in pediatric differentiated thyroid cancer (DTC) management. The dynamic risk stratification (DRS) is a well validated system for adults, but not yet for children and adolescents. This study evaluated the DRS as well as other prognostic factors in pediatric DTC. METHODS: Patients aged ≤18 years from four DTC tertiary teaching hospitals in Southern Brazil were included. Clinical characteristics were systematically retrieved, and all patients were classified according to the risk-stratification system of the 2015 American Thyroid Association pediatric DTC guidelines (ATA risk) and according to DRS (excellent, indeterminate, biochemical, or structural incomplete responses). Disease status was evaluated after initial therapy and at last follow-up visit. RESULTS: Sixty-six patients aged 14.5 ± 3.0 years were studied of whom 54 (81.8%) were girls and 62 (93.9%) had papillary thyroid carcinomas. Tumor size was 2.3 cm (P25-75 1.6-3.5); 41 (63.1%) had cervical and 18 (27.7%) distant metastasis at diagnosis. All patients underwent total thyroidectomy, and 63 (95.5%) received radioiodine. Patients were classified according to DRS after initial therapy (n = 63) as follows: 21 (33%) excellent, 13 (21%) indeterminate, 6 (9%) biochemical, and 23 (37%) structural incomplete responses. Notably, after six years (P25-75 2.7-10.0), most patients remained in the same category. Interestingly, the cutoff analysis of stimulated postoperative thyroglobulin (sPOTg) through receiver operating characteristic curve showed that the value of 37.8 ng/mL showed 81% sensitivity and 100% specificity to predict an excellent response. Prognostic factors associated with persistent disease in the univariate analysis were TNM, ATA risk, DRS, and sPOTg. CONCLUSION: DRS after initial therapy and sPOTg are strong predictors of disease outcome and might be helpful for defining follow-up strategies in pediatric DTC.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Zanella AB, Scheffel RS, Nava CF, et al. Dynamic Risk Stratification in the Follow-Up of Children and Adolescents with Differentiated Thyroid Cancer. Thyroid. 2018. PMID: 30129889. doi:10.1089/thy.2018.0075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。